Michael Garron Hospital

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Lung cancer3 trials
• Chronic kidney disease1 trial
• Chronic lymphocytic leukaemia1 trial
• Gastric and oesophageal cancer1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Recruiting3 trials
• Active, not recruiting2 trials

Lead sponsor

• Canadian Cancer Trials Group1 trial
• National Cancer Institute (NCI)1 trial
• Ottawa Hospital Research Institute1 trial
• The University of Queensland1 trial
• University Health Network, Toronto1 trial

Running trials

• Recruiting

  The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage III

  NCT04871412· Phase 3· Ottawa Hospital Research Institute· Source

  Contact: Negar Ahmadi, MD, MSc, MPH

• Recruiting

  Using ctDNA to Detect Minimal Residual Disease After Lung Cancer Resection

  NCT05254782· University Health Network, Toronto· Source

  Contact: Hajara Abdirahman

• Recruiting

  Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)

  NCT03573089· The University of Queensland· Source

  Contact: Nausheen Siddiqui

• Active, not recruiting

  Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC

  NCT03057106· Phase 2· Canadian Cancer Trials Group· Source

• Active, not recruiting

  Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia

  NCT01886872· Phase 3· National Cancer Institute (NCI)· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer2 recruiting
• Chronic kidney disease1 recruiting
• Gastric and oesophageal cancer1 recruiting